Related Experiment Video
Updated: May 27, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Acute-on-chronic liver failure: what are the implications?
Jody C Olson1, Patrick S Kamath
1Divisions of Critical Care Medicine and Gastroenterology and Hepatology, Mayo Clinic, Mayo 9 East Gastroenterology, Rochester, MN 55905, USA. olson.jody@mayo.edu
Current Gastroenterology Reports
|November 17, 2011
Summary
Acute-on-chronic liver failure (ACLF) lacks a clear definition, hindering effective clinical management. Establishing a consensus definition for ACLF is crucial for improved prevention, treatment, and patient outcomes in cirrhosis care.
Area of Science:
- Hepatology
- Internal Medicine
- Critical Care Medicine
Background:
- Acute-on-chronic liver failure (ACLF) is a recognized clinical syndrome in patients with cirrhosis.
- Despite recognition, a lack of consensus on its definition and features complicates clinical practice.
Purpose of the Study:
- To highlight the need for a clear definition of ACLF.
- To differentiate ACLF from decompensated cirrhosis, emphasizing distinct characteristics and implications.
- To underscore how a defined ACLF entity can improve patient care.
Main Methods:
- This study is a review and conceptual analysis of ACLF.
- It compares and contrasts ACLF with decompensated cirrhosis.
- It discusses the potential for a reversible component and defined insults in ACLF.
Main Results:
- Key differences exist between ACLF and decompensated cirrhosis, including prognosis and outcomes.
- ACLF may possess a reversible component and result from a specific insult.
- A clear definition is essential for clinical utility.
Conclusions:
- Defining ACLF is paramount for meaningful clinical application.
- Improved recognition and definition can enhance prevention, treatment, and patient counseling.
- Standardizing ACLF definition will advance patient care and research in liver failure.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...